NU51CK000339
Cooperative Agreement
Overview
Grant Description
Florida's response to the notice of funding opportunity to the Epidemiology and Laboratory Capacity application - Florida is a large state geographically and in population (21.54 million in 2022, with 134 million visitors annually, many of whom are international.
Given the state’s large and globally mobile population and the number of health care facilities involved, emerging infections present challenges for Florida.
The activities proposed in this grant will strengthen communication and collaboration between public health and multiple partners across the spectrum of health care to address the challenges presented in detecting, responding, preventing and controlling highly infectious diseases.
Capacity sustained by this Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding opportunity will help support program specific components in the areas of healthcare-associated infections, zoonotic, vector borne, antimicrobial resistance, and food and waterborne surveillance.
ELC funds will integrate epidemiology and laboratory capacity activities and improve health information systems for tracking trends in known and emerging infectious diseases.
Together these activities will support and enhance early detection of and rapid response to disease outbreaks, as well as evaluation of public health interventions.
Given the state’s large and globally mobile population and the number of health care facilities involved, emerging infections present challenges for Florida.
The activities proposed in this grant will strengthen communication and collaboration between public health and multiple partners across the spectrum of health care to address the challenges presented in detecting, responding, preventing and controlling highly infectious diseases.
Capacity sustained by this Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) funding opportunity will help support program specific components in the areas of healthcare-associated infections, zoonotic, vector borne, antimicrobial resistance, and food and waterborne surveillance.
ELC funds will integrate epidemiology and laboratory capacity activities and improve health information systems for tracking trends in known and emerging infectious diseases.
Together these activities will support and enhance early detection of and rapid response to disease outbreaks, as well as evaluation of public health interventions.
Awardee
Funding Goals
NOT APPLICABLE
Grant Program (CFDA)
Awarding Agency
Place of Performance
Florida
United States
Geographic Scope
State-Wide
Related Opportunity
Analysis Notes
Amendment Since initial award the total obligations have increased 2234% from $497,049 to $11,603,521.
Florida Department Of Health was awarded
Enhancing Infectious Disease Surveillance in Florida Rapid Response
Cooperative Agreement NU51CK000339
worth $11,603,521
from National Center for Emerging and Zoonotic Infectious Diseases in August 2024 with work to be completed primarily in Florida United States.
The grant
has a duration of 5 years and
was awarded through assistance program 93.317 Emerging Infections Programs.
The Cooperative Agreement was awarded through grant opportunity Epidemiology and Laboratory Capacity for Prevention and Control of Emerging Infectious Diseases (ELC).
Status
(Ongoing)
Last Modified 8/6/25
Period of Performance
8/1/24
Start Date
7/31/29
End Date
Funding Split
$11.6M
Federal Obligation
$0.0
Non-Federal Obligation
$11.6M
Total Obligated
Activity Timeline
Transaction History
Modifications to NU51CK000339
Additional Detail
Award ID FAIN
NU51CK000339
SAI Number
NU51CK000339-906696533
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
State Government
Awarding Office
75CDC1 CDC Office of Financial Resources
Funding Office
75CVL0 CDC NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES
Awardee UEI
L924BA1SEN75
Awardee CAGE
1HUA1
Performance District
FL-90
Senators
Marco Rubio
Rick Scott
Rick Scott
Modified: 8/6/25